source
- CAR-T biotech Caribou Biosciences halts two programs and seeks exit after funding shortfallCaribou Biosciences announced it is suspending two of its allogeneic CAR-T cell therapy projects. The company said it could not obtain the financing needed to keep the programs alive and is now lo…
- Bexorg receives $28 million ARPA-H grant to extend testing of revived human brain tissueBexorg, a biotech focused on brain research, was awarded $28 million by the U.S. Advanced Research Projects Agency for Health (ARPA-H). The funding will support longer-duration experiments on human…